Coronavirus update | Over 34 crore COVID-19 vaccine doses administered in country so far: Govt

A total of 9,41,03,985 persons in the age group of 18-44 across all states and UTs have received their first dose and 22,73,477 received the second dose, the Union Health Ministry said.

PTI
July 02, 2021 / 02:06 PM IST

(Representative image)

The cumulative COVID-19 vaccine doses administered in the country crossed 34 crore on Friday, the Union Health Ministry said.

A total of 9,41,03,985 persons in the age group of 18-44 across all states and UTs have received their first dose and 22,73,477 received the second dose, it said.

The ministry said 34,00,76,232 vaccine doses were administered as per the provisional report till 7 am, with over 42 lakh (42,64,123) doses being given in a span of 24 hours.

On Day-167 of the vaccination drive (July 1, 2021), out of the total 42,64,123 vaccine doses that were given, 32,80,998 beneficiaries were vaccinated for the first dose and 9,83,125 beneficiaries received the second dose of vaccine, it said.

Follow our LIVE blog for latest updates of the novel coronavirus pandemic

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The ministry said 24,51,539 vaccine doses were administered as first dose and 89,027 vaccine doses as second dose in the age group 18-44 on Thursday.

"Eight States -- Uttar Pradesh, Madhya Pradesh, Rajasthan, Tamil Nadu, Bihar, Gujarat, Karnataka and Maharashtra -- have administered more than 50 lakh first dose of COVID-19 vaccine in the age group 18-44," it said.

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level, the ministry said.

Follow our full coverage of the coronavirus pandemic here.
PTI
TAGS: #coronavirus #COVID-19 vaccine #Current Affairs #Health #Health Ministry #India
first published: Jul 2, 2021 02:06 pm